Delivery Order SPE2DB20D1004-SPE2DB25FNGXR

Award Date 5/8/25
Potential Completion Date 5/9/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the provision of Xarelto 20 mg tablets. The contract has a firm fixed price of $10,667.49 and a period of performance through May 2, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xarelto 20 mg tablets, a prescription medication, with a ceiling value of $5,418.85 and a period of performance through May 19, 2025. The contract is designated as a Firm Fixed Price agreement, with no set-aside used. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Xarelto 20 mg tablets. The $4,456.40 firm-fixed-price contract has a completion date of May 27, 2025 and is not a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xarelto 20 mg tablets. The contract has a ceiling value of $6,121.92 and runs through January 30, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,670.75, is for the delivery of Xarelto 20 mg tablets over a period ending on May 5, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Xarelto 20mg tablets. The contract has a ceiling value of $16,572.10 and a period of performance through May 15, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of XARELTO 20 MG TABLET 90S. The $11,077.91 firm fixed-price contract has a performance period through May 12, 2023 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XARELTO 20 MG tablets. The $17,748.26 firm fixed-price contract has an ultimate completion date of November 3, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide XARELTO 20 MG TABLET 90S. The contract has a firm fixed price of $3,794.29 and a period of performance through May 30, 2025. This order is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Xarelto 20 mg tablets. The contract has a ceiling value of $53,698.13 and a period of performance through December 10, 2024. The contract is a firm fixed-price delivery order, indicating the government has procured a specific quantity of the Xarelto medication at a predetermined rate. This contract does not have a set-aside designation,...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNGXR
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Xarelto 20 mg tablet. The contract has a firm fixed price of $2,025.67 and a period of performance through May 9, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is likely one of multiple orders placed under the broader IDC to fulfill the DLA's pharmaceutical and medical supply requirements, particularly for military and veteran healthcare programs.

Generated 8/10/25, 1:25 AM